Entera Bio Initiates New Research Program For Oral GLP-2
Go back to Entera Bio Initiates New Research Program For Oral GLP-2| Entrx Corporation (NASDAQ: ENTX) | Delayed: 2.89 +0.05 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.84 | 52 Week High | $0.30 | |||
| Open | $2.81 | 52 Week Low | $0.10 | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.79 | EPS | $0.00 | |||
| Volume | 18,103 | |||||

